CVE-2004-1838

Public Exploit

Description

Directory traversal vulnerability in xweb 1.0 allows remote attackers to download arbitrary files via a .. (dot dot) in the URL.

5.0
CVSS
Severity: Medium
CVSS 2.0 •
EPSS 11.36% Top 10%
Vendor Advisory secunia.com Vendor Advisory securitytracker.com Vendor Advisory autistici.org Vendor Advisory osvdb.org Vendor Advisory securityfocus.com
Affected: n/a n/a
Published at:
Updated at:

References

Link Tags
http://marc.info/?l=bugtraq&m=107997946623770&w=2 mailing list
http://www.autistici.org/fdonato/advisory/xweb1.0-adv.txt exploit patch vendor advisory
http://www.osvdb.org/4460 vdb entry vendor advisory
http://secunia.com/advisories/11186 exploit third party advisory patch vendor advisory
http://www.securityfocus.com/bid/9937 exploit vdb entry patch vendor advisory
http://securitytracker.com/id?1009514 exploit vdb entry patch vendor advisory
https://exchange.xforce.ibmcloud.com/vulnerabilities/15567 vdb entry

Frequently Asked Questions

What is the severity of CVE-2004-1838?
CVE-2004-1838 has been scored as a medium severity vulnerability.
How to fix CVE-2004-1838?
To fix CVE-2004-1838, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2004-1838 being actively exploited in the wild?
It is possible that CVE-2004-1838 is being exploited or will be exploited in a near future based on public information. According to its EPSS score, there is a ~11% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.